DITEP, Gustave Roussy, Villejuif, France.
Department of Medicine, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France.
J Hematol Oncol. 2023 Aug 8;16(1):93. doi: 10.1186/s13045-023-01486-6.
Immunotherapy has revolutionized cancer treatment, but currently, immuno-oncology agents have not been approved for patients with soft tissue sarcomas. However, there is growing evidence suggesting that immunotherapy could be an effective therapeutic strategy for this group of diseases. Here, we reviewed the latest advances of immunotherapy trials from the 2023 American Society of Clinical Oncology Annual Meeting, including some novel and encouraging combination regimens. Further research is still needed to fully understand the optimal use of these agents in sarcoma treatment.
免疫疗法已经彻底改变了癌症治疗方法，但目前，免疫肿瘤药物尚未获批用于软组织肉瘤患者。然而，越来越多的证据表明，免疫疗法可能是治疗这类疾病的有效策略。在这里，我们回顾了 2023 年美国临床肿瘤学会年会的免疫治疗试验的最新进展，包括一些新颖且令人鼓舞的联合治疗方案。仍需要进一步的研究来充分了解这些药物在肉瘤治疗中的最佳应用。
